iRhythm Technologies, Inc. (IRTC) financial statements (2021 and earlier)

Company profile

Business Address 650 TOWNSEND STREET
SAN FRANCISCO, CA 94103
State of Incorp. DE
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:33514178102111
Cash and cash equivalents892020952
Short-term investments247120589454
Other undisclosed cash, cash equivalents, and short-term investments    5
Restricted cash and investments    0
Receivables302422139
Inventory, net of allowances, customer advances and progress billings54221
Inventory54221
Other undisclosed current assets7443(4)
Total current assets:378173106120119
Noncurrent Assets
Operating lease, right-of-use asset8590
Property, plant and equipment3426965
Long-term investments and receivables 8 311
Long-term investments 8 311
Intangible assets, net (including goodwill)11111
Goodwill11111
Other noncurrent assets148333
Total noncurrent assets:134133131420
TOTAL ASSETS:512306120133138
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4541291812
Accounts payable48222
Accrued liabilities4133271610
Interest and dividends payable 000 
Deferred revenue11
Debt122 1 
Deferred revenue and credits11
Contract with customer, liability1
Other undisclosed current liabilities88   
Total current liabilities:6652302113
Noncurrent Liabilities
Long-term debt and lease obligation8186353232
Long-term debt, excluding current maturities  353232
Operating lease, liability8186
Liabilities, other than long-term debt2 000
Deferred revenue and credits00
Deferred rent credit  0
Other liabilities2    
Other undisclosed noncurrent liabilities2133  0
Total noncurrent liabilities:104119353332
Total liabilities:170171655446
Stockholders' equity
Stockholders' equity attributable to parent342135548093
Common stock00000
Additional paid in capital646396258236220
Accumulated other comprehensive income (loss)00(0)(0)(0)
Accumulated deficit(305)(260)(204)(157)(127)
Total stockholders' equity:342135548093
TOTAL LIABILITIES AND EQUITY:512306120133138

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Revenues2652151479964
Revenue, net9964
Cost of revenue(70)(52)(39)(28)(21)
Gross profit:1951621097143
Operating expenses(239)(217)(152)(98)(59)
Operating loss:(44)(55)(44)(27)(16)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
2221(2)
Interest and debt expense(2)(2)(6)(3)(3)
Loss from continuing operations before income taxes:(44)(55)(48)(29)(21)
Income tax expense(0)(0)(0)  
Net loss available to common stockholders, diluted:(44)(55)(48)(29)(21)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
Net loss:(44)(55)(48)(29)(21)
Comprehensive loss:(44)(55)(48)(29)(21)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(0)00(0)(0)
Comprehensive loss, net of tax, attributable to parent:(44)(54)(48)(29)(21)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: